Breaking News Instant updates and real-time market news.

AXON

Axovant Sciences

$22.07

-0.56 (-2.47%)

14:50
08/16/17
08/16
14:50
08/16/17
14:50

Axavont Sciences attracts a defensive option play

Axavont Sciences attracts a defensive option play. The stock down 63c to $22 and 3K Oct 10 - 15, 2X1, put spreads opened for 85c. The new position offers a max payout if shares tumble to $10 through the October expiration and is likely a play (or a hedge) on Phase 3 study results of an Alzheimer drug due late-September.

  • 18

    Aug

AXON Axovant Sciences
$22.07

-0.56 (-2.47%)

04/17/17
JEFF
04/17/17
NO CHANGE
Target $31
JEFF
Buy
Jefferies sees Axovant shares hitting $5 or $90 on Sept. data
Jefferies analyst Biren Amin last week hosted investor meetings with Axovant Sciences' incoming CEO David Hung and Vivek Ramaswamy, who is transitioning to CEO of privately held Roivant. He notes the stock is up 45% since the announcement. "This is the stupidest thing I've ever heard," Hung said of the investor theory that he believes intepirdine will fail, Amin tells investors in a research note. It seems Axovant's profile fit what Hung was looking for and he conducted extensive due diligence on both intepirdine and nelotanserin, the analyst writes. He adds that the new CEO believes both products, in aggregate, offer five opportunities for value creation. Regarding the late September Phase III readout for intepirdine in mild to moderate Alzheimer's disease, Amin believes Axovant shares could trade to $80-$90 with strong improvement on the Alzheimer's disease assessment scale, or ADS-cog, of 1.5 point at 24 weeks and positive ADCS-adl, or Alzheimer's disease cooperative study - activities of daily living outcome. With a more moderate outcome where ADS-cog ranges between 0.7 and 1.3 point improvement and ADCS-adl does not achieve statistical significance, the analyst thinks the shares could still range higher to $45-$50. If the Mindset trial fails, he thinks the shares could drop to $5. Axovant closed Thursday up $2.20 to $22.
06/14/17
OPCO
06/14/17
NO CHANGE
Target $30
OPCO
Outperform
Axovant Sciences price target raised to $30 from $26 at Oppenheimer
Oppenheimer analyst Jay Olson raised his price target for Axovant Sciences to $30 after leaving a meeting with management "incrementally more positive." The analyst is "encouraged" by management's vision which he says extends beyond dementia into other areas of high unmet need within neurology. He believes the focus on dementia with Lewy bodies and Lewy body dementia, which includes Parkinson's disease dementia, could "create significant value for shareholders." Olson sees a favorable risk/reward profile for intepirdine in the Phase 3 Mindset study with top-line results due in late September. He keeps an Outperform rating on Axovant.
07/10/17
JEFF
07/10/17
INITIATION
Target $40
JEFF
Buy
Axovant Sciences initiated with a Buy at Jefferies
Jefferies analyst Michael Yee initiated Axovant Sciences with a Buy and a $40 price target.
07/12/17
OPCO
07/12/17
NO CHANGE
OPCO
Outperform
Axovant Sciences upcoming results may drive valuation upside, says Oppenheimer
Oppenheimer analyst Jay Olson notes that Axovant Sciences faces two substantial binary events including the Phase 3 MINDSET study results at the end of September and the Phase 2 HEADWAY study results in Q4. The combination of these two events could drive up to 100% valuation upside, he contends. Further, the analyst believes the company is positioned to deliver the first new symptomatic Alzheimer's Disease drug approved by the FDA in over a decade. Olson reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

HMST

HomeStreet

$32.35

1 (3.19%)

15:48
01/16/18
01/16
15:48
01/16/18
15:48
Hot Stocks
HomeStreet raises company-wide minimum wage to $15 per hour »

HomeStreet announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

HUM

Humana

$270.41

2.39 (0.89%)

15:45
01/16/18
01/16
15:45
01/16/18
15:45
Options
Humana call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

USB

U.S. Bancorp

$57.46

0.48 (0.84%)

15:45
01/16/18
01/16
15:45
01/16/18
15:45
Hot Stocks
U.S. Bancorp names CEO Andy Cecere chairman of the board »

U.S. Bancorp, parent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

LADR

Ladder Capital

$14.53

0.94 (6.92%)

15:39
01/16/18
01/16
15:39
01/16/18
15:39
Upgrade
Ladder Capital rating change  »

Ladder Capital upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 01

    Feb

ONCE

Spark Therapeutics

$52.66

-1.41 (-2.61%)

15:30
01/16/18
01/16
15:30
01/16/18
15:30
Hot Stocks
Spark Therapeutics treatment of hemophilia A granted FDA orphan status »

Spark Therapeutics'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PX

Praxair

$161.26

-2.89 (-1.76%)

15:30
01/16/18
01/16
15:30
01/16/18
15:30
Options
$6M option print in Praxair as shares deflate »

$6M option print in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

CGI

Celadon Group

$6.20

-0.4 (-6.06%)

15:26
01/16/18
01/16
15:26
01/16/18
15:26
Periodicals
Celadon Group mentioned cautiously again by Prescience Point 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RGSE

RGS Energy

15:24
01/16/18
01/16
15:24
01/16/18
15:24
Hot Stocks
Iroquois Capital reports 6.3% stake in Real Goods Solar »

This activist stake held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$36.09

1.06 (3.03%)

15:20
01/16/18
01/16
15:20
01/16/18
15:20
Options
Notable spread in MGM as shares rally »

Notable spread in MGM as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:17
01/16/18
01/16
15:17
01/16/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
01/16/18
01/16
15:16
01/16/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLR

Continental Resources

$56.93

-0.73 (-1.27%)

15:15
01/16/18
01/16
15:15
01/16/18
15:15
Options
Continental Resources put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

OLED

Universal Display

$196.60

-1.2 (-0.61%)

15:05
01/16/18
01/16
15:05
01/16/18
15:05
Options
Universal Display call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

FRME

First Merchants

$44.20

0.31 (0.71%)

15:05
01/16/18
01/16
15:05
01/16/18
15:05
Hot Stocks
First Merchants announces company-wide raise, bonuses »

First Merchants announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

CEO

CNOOC

$159.15

-2.1 (-1.30%)

15:04
01/16/18
01/16
15:04
01/16/18
15:04
Downgrade
CNOOC rating change  »

CNOOC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRX

Valeant

$22.95

-0.8911 (-3.74%)

15:02
01/16/18
01/16
15:02
01/16/18
15:02
Recommendations
Valeant analyst commentary  »

Valeant settlement put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 18

    Jun

  • 27

    Aug

UL

Unilever; also tag UN

$54.99

0.47 (0.86%)

, UN

Unilever; also tag UL

$56.07

0.575 (1.04%)

15:00
01/16/18
01/16
15:00
01/16/18
15:00
Conference/Events
Bernstein European HPC analyst holds an analyst/industry conference call »

European Food &…

UL

Unilever; also tag UN

$54.99

0.47 (0.86%)

UN

Unilever; also tag UL

$56.07

0.575 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

BTC

Bitcoin

, BITCOIN

Bitcoin

14:59
01/16/18
01/16
14:59
01/16/18
14:59
Hot Stocks
Crypto-currencies crash bringing related companies down with them »

Shares of…

BTC

Bitcoin

BITCOIN

Bitcoin

OSTK

Overstock.com

$78.95

-1.65 (-2.05%)

AMD

AMD

$12.02

-0.12 (-0.99%)

NVDA

Nvidia

$222.98

-1.1 (-0.49%)

SQ

Square

$38.71

-2.545 (-6.17%)

MARA

Marathon Patent Group

$4.17

0.33 (8.59%)

GBTC

Bitcoin Investment Trust

$1,970.00

261.995 (15.34%)

LBCC

Long Blockchain Corp.

$5.02

-0.48 (-8.73%)

KODK

Kodak

$8.38

-0.8249 (-8.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

  • 30

    Jan

XLRE

Real Estate SPDR

$31.50

0.305 (0.98%)

, XLU

Utilities SPDR

$50.12

-0.14 (-0.28%)

14:58
01/16/18
01/16
14:58
01/16/18
14:58
Technical Analysis
Technical Take: S&P 500 breaks support, sector breadth negative »

The downward move in the…

XLRE

Real Estate SPDR

$31.50

0.305 (0.98%)

XLU

Utilities SPDR

$50.12

-0.14 (-0.28%)

XLP

Consumer Staples Sector SPDR

$56.86

0.205 (0.36%)

XLK

Technology Select Sector SPDR

$66.51

-0.3 (-0.45%)

XLF

Financial Select Sector

$29.06

-0.17 (-0.58%)

XLY

Consumer Discretionary Sector SPDR

$104.21

-0.82 (-0.78%)

XLB

S&P Select Materials SPDR

$62.43

-0.965 (-1.52%)

XLE

Energy Select Sector SPDR

$76.46

-0.9599 (-1.24%)

SPY

SPDR S&P 500 ETF Trust

$276.69

-1.23 (-0.44%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CL

Colgate-Palmolive

$75.51

0.89 (1.19%)

14:55
01/16/18
01/16
14:55
01/16/18
14:55
Options
Colgate Palmolive put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

14:55
01/16/18
01/16
14:55
01/16/18
14:55
Conference/Events
Stephens real estate services analyst holds an analyst/industry conference call »

Analysts, along with Jeff…

BPI

Bridgepoint Education

$8.32

-0.24 (-2.80%)

14:54
01/16/18
01/16
14:54
01/16/18
14:54
Hot Stocks
Calm Waters Partnership reports 5.9% passive stake in Bridgepoint Education »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$257.53

0.5 (0.19%)

14:51
01/16/18
01/16
14:51
01/16/18
14:51
Technical Analysis
Technical Earnings Preview: Goldman Sachs above breakout before earnings »

Before earnings, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Jan

  • 31

    Jan

HOG

Harley-Davidson

$51.86

-2.55 (-4.69%)

14:51
01/16/18
01/16
14:51
01/16/18
14:51
Conference/Events
Bernstein U.S. lodging/leisure analyst holds analyst/industry conference call »

U.S. Lodging &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

14:45
01/16/18
01/16
14:45
01/16/18
14:45
Conference/Events
Bernstein European food analyst holds an analyst/industry conference call »

European Food &…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.